High expression of CIN85 promotes proliferation and invasion of human esophageal squamous cell carcinoma

Hua,Xiao-Yang; Bie,Xing-Xing; Cheng,Xi; Zhang,Shu-Guang

doi:10.3892/mmr.2020.11650

High expression of CIN85 promotes proliferation and invasion of human esophageal squamous cell carcinoma

Authors:
- Xiao-Yang Hua
- Xing-Xing Bie
- Xi Cheng
- Shu-Guang Zhang
View Affiliations

Affiliations: Department of Thoracic Surgery, The First Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China, Department of Neurology, The First Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China
Published online on: November 3, 2020 https://doi.org/10.3892/mmr.2020.11650
Article Number: 12
Copyright: © Hua et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

SH3 domain‑containing kinase‑binding protein 1 (CIN85), an 85 kDa protein known to be a member of the signal adaptor family, is abnormally expressed in several human malignancies and has been found to be involved in the growth, migration and invasion of these tumors. The objective of the present study was to clarify the clinical significance of CIN85 in human esophageal squamous cell carcinoma (ESCC), as well as its in vitro functions. CIN85 expression was evaluated in 129 cases of ESCC and its adjacent normal tissues using immunohistochemistry to explore its clinical relevance and prognostic value. The functions of CIN85 in the ESCC TE1 cell line were analyzed in vitro using the interfering short hairpin RNA silencing technique. MTS, wound healing, clone formation and Transwell assays were used to detect the proliferation, migration and invasion of ESCC cells. CIN85 expression was identified mainly in ESCCs and their adjacent normal tissues, and the high expression of CIN85 was significantly associated with advanced Tumor Node Metastasis stage and lymph node metastasis. CIN85 gene silencing significantly inhibited TE1 cell proliferation, migration and invasion. These results demonstrated that CIN85 was highly expressed in advanced stage ESCC and lymph node metastasis, and played a critical role in tumor proliferation and progression. Therefore, CIN85 may be a promising therapeutic target for human ESCC.

View Figures

View References

1	Smyth EC, Lagergren J, Fitzgerald RC, Lordick F, Shah MA, Lagergren P and Cunningham D: Oesophageal cancer. Nat Rev Dis Prim. 3:170482017. View Article : Google Scholar : PubMed/NCBI
2	Murphy G, McCormack V, Abedi-Ardekani B, Arnold M, Camargo MC, Dar NA, Dawsey SM, Etemadi A, Fitzgerald RC, Fleischer DE, et al: International cancer seminars: A focus on esophageal squamous cell carcinoma. Ann Oncol. 28:2086–2093. 2017. View Article : Google Scholar : PubMed/NCBI
3	Borggreve AS, Kingma BF, Domrachev SA, Koshkin MA, Ruurda JP, van Hillegersberg R, Takeda FR and Goense L: Surgical treatment of esophageal cancer in the era of multimodality management. Ann N Y Acad Sci. 1434:192–209. 2018. View Article : Google Scholar : PubMed/NCBI
4	Saeki H, Nakashima Y, Zaitsu Y, Tsuda Y, Kasagi Y, Ando K, Imamura Y, Ohgaki K, Ito S, Kimura Y, et al: Current status of and perspectives regarding neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma. Surg Today. 46:261–267. 2016. View Article : Google Scholar : PubMed/NCBI
5	van Workum F, Berkelmans GH, Klarenbeek BR, Nieuwenhuijzen GAP, Luyer MDP and Rosman C: McKeown or Ivor Lewis totally minimally invasive esophagectomy for cancer of the esophagus and gastroesophageal junction: Systematic review and meta-analysis. J Thorac Dis. 9 (Suppl 8):S826–S833. 2017. View Article : Google Scholar : PubMed/NCBI
6	Yibulayin W, Abulizi S, Lv H and Sun W: Minimally invasive oesophagectomy versus open esophagectomy for resectable esophageal cancer: A meta-analysis. World J Surg Oncol. 14:3042016. View Article : Google Scholar : PubMed/NCBI
7	Kurakin AV, Wu S and Bredesen DE: Atypical recognition consensus of CIN85/SETA/Ruk SH3 domains revealed by target-assisted iterative screening. J Biol Chem. 278:34102–34109. 2003. View Article : Google Scholar : PubMed/NCBI
8	Kowanetz K, Husnjak K, Höller D, Kowanetz M, Soubeyran P, Hirsch D, Schmidt MHH, Pavelic K, De Camilli P, Randazzo PA, et al: CIN85 associates with multiple effectors controlling intracellular trafficking of epidermal growth factor receptors. Mol Biol Cell. 15:3155–3166. 2004. View Article : Google Scholar : PubMed/NCBI
9	Havrylov S, Redowicz MJ and Buchman VL: Emerging roles of Ruk/CIN85 in vesicle-mediated transport, adhesion, migration and malignancy. Traffic. 11:721–731. 2010. View Article : Google Scholar : PubMed/NCBI
10	Gout I, Middleton G, Adu J, Ninkina NN, Drobot LB, Filonenko V, Matsuka G, Davies AM, Waterfield M and Buchman VL: Negative regulation of PI 3-kinase by Ruk, a novel adaptor protein. EMBO J. 19:4015–4025. 2000. View Article : Google Scholar : PubMed/NCBI
11	Cascio S and Finn OJ: Complex of MUC1, CIN85 and Cbl in colon cancer progression and metastasis. Cancers (Basel). 7:342–352. 2015. View Article : Google Scholar : PubMed/NCBI
12	Wakasaki T, Masuda M, Niiro H, Jabbarzadeh-Tabrizi S, Noda K, Taniyama T, Komune S and Akashi K: A critical role of c-Cbl-interacting protein of 85 kDa in the development and progression of head and neck squamous cell carcinomas through the ras-ERK pathway. Neoplasia. 12:789–796. 2010. View Article : Google Scholar : PubMed/NCBI
13	Cascio S, Farkas AM, Hughey RP and Finn OJ: Altered glycosylation of MUC1 influences its association with CIN85: The role of this novel complex in cancer cell invasion and migration. Oncotarget. 4:1686–1697. 2013. View Article : Google Scholar : PubMed/NCBI
14	Rice TW, Ishwaran H, Hofstetter WL, Kelsen DP, Apperson-Hansen C and Blackstone EH; Worldwide Esophageal Cancer Collaboration Investigators, : Recommendations for pathologic staging (pTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals. Dis Esophagus. 29:897–905. 2016. View Article : Google Scholar : PubMed/NCBI
15	Camacho Londoño J and Philipp SE: A reliable method for quantification of splice variants using RT-qPCR. BMC Mol Biol. 17:82016. View Article : Google Scholar : PubMed/NCBI
16	Hnasko TS and Hnasko RM: The Western Blot. Methods Mol Biol. 1318:87–96. 2015. View Article : Google Scholar : PubMed/NCBI
17	Jeong DY, Lee KS, Choi JY, Chung MJ, Min YW, Kim HK, Zo JI, Shim YM and Sun JM: Surgically Resected Esophageal Squamous Cell Carcinoma: Patient Survival and Clinicopathological Prognostic Factors. Sci Rep. 10:50772020. View Article : Google Scholar : PubMed/NCBI
18	Wang Q, Wang F, Lv J, Xin J, Xie L, Zhu W, Tang Y, Li Y, Zhao X, Wang Y, et al: Interactive online consensus survival tool for esophageal squamous cell carcinoma prognosis analysis. Oncol Lett. 18:1199–1206. 2019.PubMed/NCBI
19	Jiang D, Li X, Wang H, Shi Y, Xu C, Lu S, Huang J, Xu Y, Zeng H, Su J, Hou Y and Tan L: The prognostic value of EGFR overexpression and amplification in Esophageal squamous cell Carcinoma. BMC Cancer. 15:3772015. View Article : Google Scholar : PubMed/NCBI
20	Luo N, Zhao LC, Shi QQ, Feng ZQ, Chen DL and Li J: Induction of Apoptosis in Human Leukemic Cell Lines by Diallyl Disulfide via Modulation of EGFR/ERK/PKM2 Signaling Pathways. Asian Pac J Cancer Prev. 16:3509–3515. 2015. View Article : Google Scholar : PubMed/NCBI
21	Take H, Watanabe S, Takeda K, Yu ZX, Iwata N and Kajigaya S: Cloning and characterization of a novel adaptor protein, CIN85, that interacts with c-Cbl. Biochem Biophys Res Commun. 268:321–328. 2000. View Article : Google Scholar : PubMed/NCBI
22	Watanabe S, Take H, Takeda K, Yu ZX, Iwata N and Kajigaya S: Characterization of the CIN85 adaptor protein and identification of components involved in CIN85 complexes. Biochem Biophys Res Commun. 278:167–174. 2000. View Article : Google Scholar : PubMed/NCBI
23	Niiro H, Jabbarzadeh-Tabrizi S, Kikushige Y, Shima T, Noda K, Ota S, Tsuzuki H, Inoue Y, Arinobu Y, Iwasaki H, et al: CIN85 is required for Cbl-mediated regulation of antigen receptor signaling in human B cells. Blood. 119:2263–2273. 2012. View Article : Google Scholar : PubMed/NCBI
24	Brett TJ1, Traub LM and Fremont DH: Accessory protein recruitment motifs in clathrin-mediated endocytosis. Structure. 10:797–809. 2002. View Article : Google Scholar : PubMed/NCBI
25	Legendre-Guillemin V, Wasiak S, Hussain NK, Angers A and McPherson PS: ENTH/ANTH proteins and clathrin-mediated membrane budding. J Cell Sci. 117:9–18. 2004. View Article : Google Scholar : PubMed/NCBI
26	Donaldson JG and Jackson CL: ARF family G proteins and their regulators: Roles in membrane transport, development and disease. Nat Rev Mol Cell Biol. 12:362–375. 2011. View Article : Google Scholar : PubMed/NCBI
27	Lanier MH, McConnell P and Cooper JA: Cell Migration and Invadopodia Formation Require a Membrane-binding Domain of CARMIL2. J Biol Chem. 291:1076–1091. 2016. View Article : Google Scholar : PubMed/NCBI
28	Nam JM, Onodera Y, Mazaki Y, Miyoshi H, Hashimoto S and Sabe H: CIN85, a Cbl-interacting protein, is a component of AMAP1-mediated breast cancer invasion machinery. EMBO J. 26:647–656. 2007. View Article : Google Scholar : PubMed/NCBI
29	Lito P, Mets BD, Kleff S, O'Reilly S, Maher VM and McCormick JJ: Evidence that sprouty 2 is necessary for sarcoma formation by H-Ras oncogene-transformed human fibroblasts. J Biol Chem. 283:2002–2009. 2008. View Article : Google Scholar : PubMed/NCBI
30	Samoylenko A, Vynnytska-Myronovska B, Byts N, Kozlova N, Basaraba O, Pasichnyk G, Palyvoda K, Bobak Y, Barska M, Mayevska O, et al: Increased levels of the HER1 adaptor protein Rukl/CIN85 contribute to breast cancer malignancy. Carcinogenesis. 33:1976–1984. 2012. View Article : Google Scholar : PubMed/NCBI
31	Bögler O, Furnari FB, Kindler-Roehrborn A, Sykes VW, Yung R, Huang HJ and Cavenee WK: SETA: A novel SH3 domain-containing adapter molecule associated with malignancy in astrocytes. Neuro-oncol. 2:6–15. 2000. View Article : Google Scholar : PubMed/NCBI
32	Hashimoto S, Hirose M, Hashimoto A, Morishige M, Yamada A, Hosaka H, Akagi K, Ogawa E, Oneyama C, Agatsuma T, et al: Targeting AMAP1 and cortactin binding bearing an atypical src homology 3/proline interface for prevention of breast cancer invasion and metastasis. Proc Natl Acad Sci USA. 103:7036–7041. 2006. View Article : Google Scholar : PubMed/NCBI
33	Sato S, Zhao Y, Imai M, Simister PC, Feller SM, Trackman PC, Kirsch KH and Sonenshein GE: Inhibition of CIN85-mediated invasion by a novel SH3 domain binding motif in the lysyl oxidase propeptide. PLoS One. 8:772882013. View Article : Google Scholar